ProShares UltraShort Dow30

3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma

10 May 2018 09:01:35 By Nasdaq GlobeNewswire

3D Signatures Inc. Announces Successful Scoring Model Development and Analytical Validation of the Telo-HL(TM) Test for Hodgkin’s Lymphoma

03 Apr 2018 08:02:04 By Nasdaq GlobeNewswire

3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC™ Test in Prostate Cancer

28 Mar 2018 08:01:29 By Nasdaq GlobeNewswire

3D Signatures Inc. and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung Cancer

06 Mar 2018 08:01:20 By Nasdaq GlobeNewswire

3D Signatures Reports Quarter Ended December 31, 2017 Financial Results

01 Mar 2018 17:00:14 By Nasdaq GlobeNewswire

3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL™ Test for Hodgkin’s Lymphoma

20 Feb 2018 08:00:50 By Nasdaq GlobeNewswire

3D Signatures Inc. Announces Changes To Its Board of Directors

12 Feb 2018 16:30:12 By Nasdaq GlobeNewswire

3D Signatures Inc. Announces the Closing of its Non-Brokered Private Placement

05 Dec 2017 18:53:38 By Nasdaq GlobeNewswire

3D Signatures Inc. Announces Upsizing of $1,500,000 Private Placement, the Appointment of a New Director and Reports on AGM Results

01 Dec 2017 08:15:17 By Nasdaq GlobeNewswire

3D Signatures Reports First Quarter Financial Results for Fiscal 2018

29 Nov 2017 19:12:10 By Nasdaq GlobeNewswire

3D Signatures Inc. Announces Non-Brokered Private Placement to Raise $1,500,000 and Updates Previously Announced Brokered Private Placement

27 Nov 2017 08:00:44 By Nasdaq GlobeNewswire

3D Signatures Reports Financial Results for 2017

24 Oct 2017 18:50:10 By Nasdaq GlobeNewswire

3D Signatures Announces Changes to Its Board of Directors and Audit Committee

19 Oct 2017 07:00:43 By Nasdaq GlobeNewswire

3D Signatures Announces Completion of Stage 3 of Hodgkin’s Lymphoma Test Validation Program

10 Oct 2017 09:00:44 By Nasdaq GlobeNewswire

3D Signatures Announces Change to Its Board of Directors

10 Oct 2017 07:59:40 By Nasdaq GlobeNewswire

3D Signatures Announces Close of Private Placement With Strategic Partner and Prospectus Update

04 Oct 2017 18:05:31 By Nasdaq GlobeNewswire

3D Signatures Announces Private Placement With Strategic Partner and Prospectus Update

03 Oct 2017 16:51:12 By Nasdaq GlobeNewswire

3D Signatures Announces Change to Its Board of Directors

11 Aug 2017 18:35:39 By Nasdaq GlobeNewswire

3D Signatures Inc. Announces Grant of Stock Options

27 Jun 2017 07:30:23 By Nasdaq GlobeNewswire

3D Signatures Advances Hodgkin’s Lymphoma Test

08 Jun 2017 07:00:39 By Nasdaq GlobeNewswire